AGRX
Agile Therapeutics
AGRX
AGRX
Delisted
AGRX was delisted on the 25th of March, 2024.
73 hedge funds and large institutions have $79.5M invested in Agile Therapeutics in 2021 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 17 increasing their positions, 25 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
31% less capital invested
Capital invested by funds: $116M → $79.5M (-$36.5M)
32% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 25
Holders
73
Holding in Top 10
1
Calls
$1.43M
Puts
$275K
Top Buyers
| 1 | +$798K | |
| 2 | +$337K | |
| 3 | +$291K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$283K |
| 5 |
NIM
Needham Investment Management
New York
|
+$283K |
Top Sellers
| 1 | -$4.5M | |
| 2 | -$1M | |
| 3 | -$662K | |
| 4 |
DCM
DG Capital Management
New York
|
-$634K |
| 5 |
Squarepoint
New York
|
-$330K |